RAC
Click for more information
1.11% $1.83 race oncology ltd

Probably relates to what the FDA want to see for a breakthrough...

  1. Mason14
    935 Posts.
    lightbulb Created with Sketch. 10726
    clock Created with Sketch.
    21/06/24
    12:56
    Post #: 74424874
    Probably relates to what the FDA want to see for a breakthrough therapy designation.

    What mechanism do you think Bisantrene was targeting to overcome therapy acquired resistance in the P2 relapsed/refractory pediatric AML BIS + ARA-C and P2 relapsed/refractory AML BIS + CLO + FLO combination trials? Plenty of preclinical data supporting FTO resensitizing resistant cancer to the therapy it was previously resistant to.

    If it is not FTO, it is still significant.
    RAC Price at posting: $1.88 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 26  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83 		Change
0.020(1.11%) 		Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.